Loading clinical trials...
Loading clinical trials...
Transcutaneous Bilirubinometry in Neonatal Hyperbilirubinemia During and After Phototherapy: a Randomized Controlled Trial
A randomized Controlled trial comparing the use of transcutaneous bilirubinometry to serum bilirubin measurements (via blooddraws = standard care) in neonates born after a gestational age \> 32 weeks and \< 15 days of age treated with Phototherapy for neonatal hyperbilrubinemia.
A randomized Controlled trial comparing the use of transcutaneous bilirubinometry to serum bilirubin measurements (via blooddraws = standard care) in neonates born after a gestational age \> 32 weeks and \< 15 days of age treated with Phototherapy for neonatal hyperbilrubinemia. Main outcome measurement is the number of blooddraws for measurement of bilirubin. Secondary outcome measurements are duration of phototherapy and hospitalisation.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
Isala Klinieken
Zwolle, Overijssel, Netherlands
Start Date
January 1, 2026
Primary Completion Date
December 31, 2026
Completion Date
May 1, 2027
Last Updated
August 2, 2024
130
ESTIMATED participants
Transcutaneous bilirubinometry
DIAGNOSTIC_TEST
Serum bilirubin
DIAGNOSTIC_TEST
Lead Sponsor
Princess Amalia Children's Clinic
NCT06517862
NCT07346976
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06687746